| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.81▼ | 1.83▼ | 1.83▼ | 1.80▼ | 1.99▼ |
| MA10 | 1.85▼ | 1.86▼ | 1.86▼ | 1.90▼ | 2.23▼ |
| MA20 | 1.92▼ | 1.93▼ | 1.93▼ | 2.03▼ | 2.37▼ |
| MA50 | 2.11▼ | 2.14▼ | 2.18▼ | 2.28▼ | 2.76▼ |
| MA100 | 2.29▼ | 2.35▼ | 2.41▼ | 2.40▼ | 3.26▼ |
| MA200 | 2.50▼ | 2.54▼ | 2.65▼ | 2.66▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.001▼ | 0.001▲ | -0.018▼ | N/A |
| RSI | 29.911▼ | 29.664▼ | 30.161▼ | 36.307▼ | N/A |
| STOCH | 17.984▼ | 18.166▼ | 18.074▼ | 19.316▼ | 9.700▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -78.278▼ | -95.150▼ |
| CCI | -103.104▼ | -108.936▼ | -108.936▼ | -101.039▼ | -150.467▼ |
|
Wednesday, December 12, 2018 05:17 AM
AzurRx BioPharma (NASDAQ:AZRX) is acquiring royalty and milestone obligations to its lead drug candidate MS1819-SD, a recombinant lipase for exocrine pancreatic insufficiency, from Protea ...
|
|
Wednesday, December 12, 2018 04:02 AM
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“AzurRx” or the “Company”), a company specializing in the development of no...
|
|
Wednesday, December 12, 2018 04:00 AM
NEW YORK, Dec. 12, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/18 | 1.81 | 1.85 | 1.79 | 1.79 | 65,359 |
| 11/12/18 | 1.77 | 1.84 | 1.70 | 1.70 | 48,182 |
| 10/12/18 | 1.81 | 1.89 | 1.6901 | 1.85 | 70,545 |
| 07/12/18 | 1.92 | 1.92 | 1.77 | 1.81 | 23,778 |
| 06/12/18 | 1.99 | 1.99 | 1.86 | 1.86 | 117,406 |
| 04/12/18 | 2.00 | 2.00 | 1.962 | 1.99 | 13,713 |
| 03/12/18 | 2.00 | 2.02 | 1.966 | 2.02 | 19,449 |
| 30/11/18 | 2.03 | 2.03 | 1.95 | 1.95 | 97,087 |
| 29/11/18 | 2.00 | 2.05 | 1.95 | 2.05 | 94,175 |
| 28/11/18 | 2.01 | 2.05 | 1.98 | 1.98 | 24,860 |
|
|
||||
|
|
||||
|
|
||||
|
|